These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32578463)

  • 1. Early detection of infectious complications during induction therapy for acute leukemia with serial C-reactive protein biomarker assessment.
    Shimony S; Rozovski U; Sudry N; Yeshurun M; Yahav D; Raanani P; Wolach O
    Leuk Lymphoma; 2020 Nov; 61(11):2708-2713. PubMed ID: 32578463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin versus C-Reactive Protein as a Biomarker for Prediction of Bacterial Infection in Children with Febrile Neutropenia in Acute Leukemia.
    Nahar A; Jamal CY; Refat R; Chowdhury T; Akter S; Karim A; Rahman MA; Yeamin MB; Saha BK; Hossain F; Rabbany MA
    Mymensingh Med J; 2023 Jan; 32(1):76-82. PubMed ID: 36594305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
    Yoshino N; Kimura SI; Matsuoka A; Meno T; Ishikawa T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Misaki Y; Yoshimura K; Gomyo A; Okada Y; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Wada H; Nakasone H; Kako S; Kanda Y
    J Infect Chemother; 2023 Apr; 29(4):384-390. PubMed ID: 36669687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.
    Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N
    Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings.
    Lappalainen M; Hämäläinen S; Romppanen T; Pulkki K; Pyörälä M; Koivula I; Jantunen E; Juutilainen A
    Eur J Haematol; 2020 Dec; 105(6):731-740. PubMed ID: 32740997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
    Alali M; Mayampurath A; Dai Y; Bartlett AH
    Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal.
    Shilpakar R; Paudel BD; Neupane P; Shah A; Acharya B; Dulal S; Wood LA; Shahi R; Khanal U; Poudyal BS
    J Glob Oncol; 2019 Sep; 5():1-6. PubMed ID: 31526283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation.
    Kameda K; Kimura SI; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Tamaki M; Kusuda M; Akahoshi Y; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Tanihara A; Wada H; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Bone Marrow Transplant; 2019 May; 54(5):707-716. PubMed ID: 30171223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Microbiological Characteristics of Febrile Neutropenia During Induction Chemotherapy in Adults With Acute Leukemia.
    Rajme-López S; Tello-Mercado AC; Ortíz-Brizuela E; Martínez-Guerra BA; Tamez-Torres KM; Román-Montes CM; González-Lara MF; Ponce-de-León A
    Cancer Rep (Hoboken); 2024 Aug; 7(8):e2129. PubMed ID: 39158198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study.
    Metais A; Torregrosa Diaz JM; Gallego Hernanz MP; Pichon M; Desmier D; Roblot F; Rammaert B
    J Infect; 2022 Jan; 84(1):1-7. PubMed ID: 34715238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
    Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
    Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
    Netterberg I; Karlsson MO; Nielsen EI; Quartino AL; Lindman H; Friberg LE
    Br J Clin Pharmacol; 2018 Mar; 84(3):490-500. PubMed ID: 29178353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers to predict infection and infection-related complications during chemotherapy-induced neutropenia in acute myeloid leukaemia: a pilot study.
    van de Geer A; Zandstra J; Tanck MWT; Nur E; van Mierlo G; Jongerius I; van Bruggen R; Zeerleder SS; Kuijpers TW
    Br J Haematol; 2021 Jun; 193(5):1008-1012. PubMed ID: 33829503
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia.
    Hazan G; Ben-Shimol S; Fruchtman Y; Abu-Quider A; Kapelushnik J; Moser A; Falup-Pecurariu O; Greenberg D
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e275-9. PubMed ID: 24276046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of infectious events by high-sensitivity C-reactive protein level before undergoing chemotherapy for acute myeloid leukaemia.
    Sato M; Kako S; Oshima K; Sato K; Terasako K; Kimura S; Nakasone H; Okuda S; Yamazaki R; Higuchi T; Nishida J; Kanda Y
    Scand J Infect Dis; 2010; 42(2):97-101. PubMed ID: 20082574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia.
    Arıkan K; Karadağ-Oncel E; Aytac S; Cengiz AB; Duygu Cetinkaya F; Kara A; Ceyhan M
    Cytokine; 2021 Dec; 148():155692. PubMed ID: 34500368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic C-reactive protein elevation in neutropenic children.
    Sugiura S; Ito T; Koyama N; Sasaki N; Ikai H; Imanaka Y
    Pediatr Int; 2017 Jan; 59(1):23-28. PubMed ID: 27362735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia.
    Erbaş İC; Çakıl Güzin A; Özdem Alataş Ş; Karaoğlu Asrak H; Akans İ; Akyol Ş; Özlü C; Tüfekçi Ö; Yılmaz Ş; Ören H; Belet N
    Turk J Haematol; 2023 Aug; 40(3):143-153. PubMed ID: 37525503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia.
    Kubo H; Imataki O; Kubo YH; Uemura M
    PLoS One; 2022; 17(3):e0263623. PubMed ID: 35298471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
    Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
    Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.